This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The treatment strategy for a patient with endometriosis depends whether the patient has infertility or secondary dysmenorrhea (pelvic pain).

In cases where pelvic pain is associated with endometriosis then treatment is indicated even if there is only mild disease found at laparoscopy. A prolonged period of medical treatment (hormonal treatment) is required to treat endometriosis. In general, a treatment period of at least 6 months is undertaken.

In cases of subfertility associated with endometriosis, there is no evidence that medical therapies improve fertility. The limited data available suggests that surgery can improve a woman's chances of conceiving (1,2,3).

NICE state that should:

  • offer laparoscopic ovarian cystectomy with excision of the cyst wall to women with endometriomas, because this improves the chance of spontaneous pregnancy and reduces recurrence (4)

Reference:

  • Hughes E et al (1999). Ovulation suppression versus placebo in the treatment of endometriosis (Cochrane Review). In: The Cochrane Library Issue 3. Oxford: Update Software, 1999.
  • Prescriber (2004); 15(16):18-22.
  • Kroon N, Reginald P. Medical management of chronic pelvic pain. Curr. Obs. & Gynae. 2005; 15 (5): 285-290.
  • NICE (September 2017). Endometriosis: diagnosis and management

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.